Droxidopa Capsule
Product Images NDC 31722-010

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 31722-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Droxidopafigure1 (Droxidopafigure1)

A line graph showing the mean change in dizziness over 8 weeks during a double-blind treatment phase comparing Droxidopa and Placebo groups. The y-axis measures mean change in dizziness, with values ranging from 0 to -3.5, and the x-axis represents weeks in treatment (baseline, 1, 2, 4, 8 weeks). Droxidopa shows a greater reduction in dizziness over time compared to Placebo, with an indication of statistical significance at week 1 (p < 0.05). Error bars are shown for each data point.*

FDA Label Image

Droxidopafigure2 (Droxidopafigure2)

A bar chart comparing the percent of subjects reporting different levels of improvement on OHSA Question 1, between placebo and Droxidopa groups. The x-axis represents improvement scores from -8 (worse) to 8 (better), and the y-axis shows percent of subjects. White bars indicate placebo; black bars indicate Droxidopa.*

FDA Label Image

Droxidopastructure (Droxidopastructure)

Chemical structure diagram of Droxidopa, showing its molecular framework including a benzene ring with hydroxyl groups and a side chain containing amino and carboxyl functional groups.*

FDA Label Image

Droxidopa100mg90scountlabel

Droxidopa Capsules 100 mg oral dose label from Camber Pharmaceuticals, Inc. The label shows the NDC number 31722-014-90, packaging details indicating 90 capsules, and storage instructions. It includes warnings, a U.S. contact number, and mentions manufacturing by Anorva Pharma Pvt. Ltd. in India. A designated space for batch coding is also visible.*

FDA Label Image

Droxidopa200mg90scountlabel

Droxidopa Capsules 200 mg oral dosage form, supplied in a bottle containing 90 capsules. The label shows Camber Pharmaceuticals, Inc. as the labeler and lists storage instructions, dosage details, and manufacturing information. The label includes the NDC code 31722-015-90 and cautions to keep out of reach of children.*

FDA Label Image

Droxidopa300mg90scountlabel

Droxidopa 300 mg capsules label by Camber Pharmaceuticals, Inc. The label states the dosage strength of 300 mg per capsule and indicates a package count of 90 capsules. It includes storage instructions, usage warning, and manufacturer information, along with a barcode and contact number for the U.S. region.*

FDA Label Image

Logo

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.